[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352102-105":59,"doc-detail-352102-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-oncogenic-potential-of-sox12-a-comprehensive-and-perspective-view","The oncogenic potential of SOX12: a comprehensive and perspective view","","Sex-determining region Y-box 12 (SOX12) is a conserved HMG-box DNA-binding transcription factor subfamily member with reported oncogenic roles across multiple malignancies. Prior reviews do not provide a systematic, cross-cancer synthesis of SOX12-mediated regulatory networks, leaving gaps in mechanistic understanding and therapeutic target identification. This review consolidates SOX12 expression and oncogenic function across major tumor categories, dissects ceRNA and canonical signaling, metabolic and immune microenvironment regulation, and evaluates prognostic and targetable translational implications.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-oncogenic-potential-of-sox12-a-comprehensive-and-perspective-view/352102/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-oncogenic-potential-of-sox12-a-comprehensive-and-perspective-view/352102.png","ImageObject",300,407,{"name":92,"@type":93},"dhado","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is SOX12 and why is it important in cancer biology?","Question",{"text":112,"@type":113},"SOX12 is a SOXC transcription factor characterized by a conserved HMG-box DNA-binding domain. It can drive oncogenic roles by regulating downstream gene networks in multiple tumor types.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which regulatory mechanisms does the review emphasize for SOX12 in tumors?",{"text":117,"@type":113},"The review highlights ceRNA (competing endogenous RNA) networks, activation of canonical pathways such as PI3K/AKT/mTOR and Wnt/β-catenin, metabolic reprogramming, and modulation of the tumor immune microenvironment.",{"name":119,"@type":110,"acceptedAnswer":120},"How does SOX12 have clinical value according to the document?",{"text":121,"@type":113},"SOX12 is presented as a prognostic biomarker and a therapeutic target. The review also discusses potential targeting strategies, including HMG-box domain inhibitors and interventions affecting ceRNA network crosstalk.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352102,1790956735,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},5909893218464,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Leng et al. Journal of Translational Medicine (2026) 24:1085  \n[https://doi.org/10.1186/s12967-026-08349-x](https://doi.org/10.1186/s12967-026-08349-x)  \nJournal of Translational Medicine  \nREVIEW Open Access  \nThe oncogenic potential of SOX12: a comprehensive and perspective view  \nHaokun Leng1, Yuanqi Liu2 and Lei Wu3*  \nAbstract  \nBackground Sex-determining region Y-box 12 (SOX12), a key member of the SOXC transcription factor subfamily, exerts oncogenic roles in multiple malignancies via its conserved HMG-box DNA-binding domain. Although existing studies have reported its abnormal expression and functional implications in various tumors, previous reviews lack a systematic summary of SOX12-mediated regulatory networks across cancers, failing to address research gaps and potential therapeutic targets.  \nMain body This review comprehensively summarizes SOX12’s expression patterns and oncogenic functions in digestive, reproductive, hematologic, and other tumor types. We systematically dissect its core molecular mechanisms, including competing endogenous RNA (ceRNA) networks, activation of canonical signaling  \npathways (e. g. PI3K/AKT/mTOR, Wnt/β-catenin), metabolic reprogramming, and modulation of the tumor immune microenvironment. Additionally, we highlight SOX12’s clinical potential as a prognostic biomarker and therapeutic target, discussing novel targeting strategies such as HMG-box domain inhibitors and ceRNA network intervention. Conclusions SOX12 serves as a critical “metabolic-immune” cross-regulatory node in tumors, with conserved oncogenic mechanisms across cancer types. Its abnormal expression is closely associated with malignant phenotypesand poor prognosis, supporting its dual value as a prognostic indicator and therapeutic target. Future research should focus on exploring its post-translational modifications, synergistic mechanisms with other SOX family members, and conducting large-scale clinical trials to validate its translational potential.  \nFacts  \n• Summarizes SOX12’s expression patterns and oncogenic roles across digestive, reproductive, and hematological tumors.  \n• Systematically dissects SOX12-mediated regulatory networks, including ceRNA crosstalk and canonical signaling pathways.  \n• Highlights SOX12’s dual functions in metabolic reprogramming and tumor immune microenvironment modulation.  \n• Discusses novel targeting strategies (e. g., ubiquitination regulation) and clinical translation potential of SOX12 . Keywords SOX12, Tumor, Signal pathway, Prognostic marker, Therapeutic target  \n*Correspondence: Lei Wu [wulei2015h@163.com](wulei2015h@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nLeng et al. Journal of Translational Medicine (2026) 24:1085 Page 2 of 16  \nGraphical Abstract  \nIntroduction  \nBasic characteristics of SOX12 protein  \nTr","cbCairRXS8RIQOl6","https://ap.wps.com/l/cbCairRXS8RIQOl6","pdf",4926088,16,"English","# Abstract\n# Main body\n## Expression patterns and oncogenic functions\n## Core molecular mechanisms\n## Clinical potential and targeting strategies\n# Conclusions\n# Facts","[{\"question\":\"What is SOX12 and why is it important in cancer biology?\",\"answer\":\"SOX12 is a SOXC transcription factor characterized by a conserved HMG-box DNA-binding domain. It can drive oncogenic roles by regulating downstream gene networks in multiple tumor types.\"},{\"question\":\"Which regulatory mechanisms does the review emphasize for SOX12 in tumors?\",\"answer\":\"The review highlights ceRNA (competing endogenous RNA) networks, activation of canonical pathways such as PI3K/AKT/mTOR and Wnt/β-catenin, metabolic reprogramming, and modulation of the tumor immune microenvironment.\"},{\"question\":\"How does SOX12 have clinical value according to the document?\",\"answer\":\"SOX12 is presented as a prognostic biomarker and a therapeutic target. The review also discusses potential targeting strategies, including HMG-box domain inhibitors and interventions affecting ceRNA network crosstalk.\"}]","The oncogenic potential of SOX12: a comprehensive and perspective view | PDF",1790097701,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6a403a40964dda2cff77cff9129c0933.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/40b3adb258959beb9055c96846fa4385.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d56518b8386833abf51a46964fb97b05.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/500b139aa8a4d8b35d1b0cb064f35ac1.webp",980,1306]